Craig Beavers discusses recent developments in hypertension management and the clinical implications of the Bax Hypertension and KARDIA-3 trials with Shelby Tungate from the UNC Eshelman School of Pharmacy.
Shelby Tungate Lopez, PharmD, CPP, BCACP, MPA
Advertisement
Articles by Shelby Tungate Lopez, PharmD, CPP, BCACP, MPA
Advertisement
Latest Updated Articles
KARDIA-3 Versus Cardia: New Frontiers in Hypertension CarePublished: October 7th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications
2
Gluteus Maximus Muscle Shape Changes Tied to Aging, Frailty, and Type 2 Diabetes
3
Understanding Cyclobenzaprine Hydrochloride: An Emerging Therapy for Fibromyalgia
4
FDA Approves Sibeprenlimab for Patients with IgAN
5
